CELLECTIS S A's ticker is CLLS and the CUSIP is 15117K103. A total of 58 filers reported holding CELLECTIS S A in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $21 | – | 10 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 10 | -99.5% | 0.00% | – |
| Q1 2022 | $9,000 | -81.2% | 1,994 | -66.3% | 0.00% | – |
| Q4 2021 | $48,000 | +65.5% | 5,914 | +153.6% | 0.00% | – |
| Q3 2021 | $29,000 | +52.6% | 2,332 | +94.0% | 0.00% | – |
| Q2 2021 | $19,000 | -48.6% | 1,202 | -35.2% | 0.00% | – |
| Q1 2021 | $37,000 | -30.2% | 1,854 | -5.6% | 0.00% | – |
| Q4 2020 | $53,000 | +82.8% | 1,964 | +25.7% | 0.00% | – |
| Q3 2020 | $29,000 | 0.0% | 1,562 | -1.9% | 0.00% | – |
| Q2 2020 | $29,000 | +141.7% | 1,593 | +18.4% | 0.00% | – |
| Q1 2020 | $12,000 | -50.0% | 1,345 | -2.9% | 0.00% | – |
| Q4 2019 | $24,000 | +26.3% | 1,385 | -24.1% | 0.00% | – |
| Q3 2019 | $19,000 | +850.0% | 1,824 | +1347.6% | 0.00% | – |
| Q2 2019 | $2,000 | -60.0% | 126 | -55.9% | 0.00% | – |
| Q1 2019 | $5,000 | -58.3% | 286 | -31.1% | 0.00% | – |
| Q2 2018 | $12,000 | – | 415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Long Focus Capital Management, LLC | 4,487,293 | $7,089,923 | 0.25% |
| OPPENHEIMER & CO INC | 121,420 | $191,844 | 0.00% |
| CREDIT SUISSE AG/ | 1,438,255 | $2,272,443 | 0.00% |
| Baillie Gifford | 1,164,009 | $1,839,135 | 0.00% |
| PRINCIPAL FINANCIAL GROUP INC | 656,600 | $1,037,428 | 0.00% |
| Capital International Investors | 1,848,804 | $2,921,110 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,095,966 | $1,731,626 | 0.00% |
| EverSource Wealth Advisors, LLC | 13 | $21 | 0.00% |
| Qube Research & Technologies Ltd | 40 | $63 | 0.00% |
| Tower Research Capital LLC (TRC) | 111 | $175 | 0.00% |